GFM
RPRX icon

GF Fund Management’s Royalty Pharma RPRX Stock Holding History

GF Fund Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Sell
9,065
-531
-6% -$27.6K 0.01% 214
2026
Q1 		$460K Buy
9,596
+1,200
+14% +$52.6K 0.01% 222
2025
Q4 		$324K Sell
8,396
-905
-10% -$34.5K 0.01% 250
2025
Q3 		$328K Sell
9,301
-2,076
-18% -$75.2K 0.01% 245
2025
Q2 		$410K Hold
11,377
– – 0.01% 269
2025
Q1 		$354K Buy
11,377
+2,048
+22% +$64.9K 0.01% 281
2024
Q4 		$238K Buy
+9,329
New +$247K 0.01% 274

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's RPRX Position: Q2 2026 in Review

GF Fund Management reduced its Royalty Pharma (RPRX) stake by 5.5% in Q2 2026, selling an estimated $27.6K and leaving 9,065 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #214.

GF Fund Management first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • GF Fund Management held 9,065 shares of Royalty Pharma worth $508K as of Q2 2026.
  • GF Fund Management sold 531 Royalty Pharma shares in Q2 2026, an estimated $27.6K.
  • Royalty Pharma made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #214 holding.
  • GF Fund Management first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.